Navigation Links
Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Date:8/19/2007

steady flow of clinical information in the second half of 2007 as our clinical studies progress to broader populations."

About Trodusquemine (MSI-1436)

Trodusquemine (MSI-1436) is the first drug candidate that acts both centrally and peripherally to selectively inhibit the established and validated enzyme target, protein tyrosine phosphatase 1B (PTP-1B). The dual locations of MSI-1436 action make the drug a promising candidate for both obesity and type 2 diabetes. By inhibiting PTP-1B, trodusquemine is expected to decrease appetite and normalize blood sugar as PTB-1B is central to both the insulin and leptin pathways. Based on this unique mechanism of action, trodusquemine has the potential to bridge the treatment for two of the most serious metabolic diseases, obesity and type 2 diabetes. In addition, trodusquemine has overcome selectivity concerns that other compounds that target PTP-1B have failed to overcome. Preclinical studies demonstrate that trodusquemine is a potent, highly-selective and reversible inhibitor of PTP-1B. In vitro kinetics demonstrate that trodusquemine is an allosteric, noncompetitive inhibitor of PTP-1B, binding to a site different from the catalytic site of PTP-1B. Data also demonstrate that trodusquemine can produce consistent, sustainable weight loss in a variety of animal models and appears to overcome metabolic readjustment, which often limits sustained weight loss during caloric restriction. Trodusquemine suppresses appetite, causes differential weight loss, reduces adipocyte size, reduces body fat (with no reduction of lean mass), and improves glucose tolerance via inhibition of a unique combination of signaling pathways in a mouse model of diet induced obesity (DIO).

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefin
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Agreement reinforces ... treatments   ViiV Healthcare and Desano ... production in China of dolutegravir. The ... pharmaceutical ingredient (API), and will allow ViiV Healthcare to offer ... under the name Tivicay®) for China ...
(Date:7/1/2015)... 1, 2015 Eli Lilly and Company (NYSE: ... quarter of 2015 on Thursday, July 23, 2015. Lilly will ... investment community and media to further detail the company,s financial ... a.m. EDT. Investors, media and the general public can access ... that will be posted on Lilly,s website at www.lilly.com ...
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
Breaking Medicine Technology:ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced that they will welcome four new members to their industry leading ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... as organically raised chickens and eggs. Eating organic foods and products can help ... and more environmentally friendly than production chicken farming. Choosing home raised chickens and ...
(Date:7/1/2015)... ... 01, 2015 , ... The Collaborative for Children and Families (CCF) announced that ... will allow CCF to improve quality of care and save costs for the child ... to many changes in New York’s Medicaid system. Experts agree that children need thorough ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... longer taboo with teenagers to fix noses and chins with plastic surgery when they’re ... Reconstructive Surgeons (ASPS) more than 236,000 cosmetic procedures were performed on patients ages 19 ...
(Date:7/1/2015)... ... ... The 28th annual Charity Horse Show hosted by the Mid-South Horse Show Association ... Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth Town. , ... silent auction and concessions. , Horses and riders from around the country will participate ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3
... women to suffer eyelid droop as they age, scientists have discovered. ... view photographs// of the eyes of 256 people between the ages ... age of 35, the lower eyelid started to sag, the effect ... is caused by the increased laxity of eyelid tissues with age. ...
... fare better if they kept the bed for sleep and ... study found that taking sleeping pills worked in the// short-term, ... period. , Insomnia is defined as trouble falling asleep, ... the morning without being able to get back to sleep.Less ...
... young people is leading to an alarming rise in liver ... having increased in men for some time//, Professor Liam Donaldson ... signs of permanent liver damage at an earlier age. ... liver - is irreversible, although treatment can prevent it from ...
... The armpit smells of old ladies are the latest ... they warn that those of young men may have ... effect may be due to the human ability to ... which signal aggression, reports "New Scientist" magazine. ...
... believe a common liver disease may be caused by the ... thought to affect around one in four people in developed ... is currently untreatable, and one in ten sufferers go on ... the risk that cancer will develop in the organ.The damage ...
... allergy to a common chemical found in dyes, warn scientists. ... to months of pain and discomfort. The problem is not ... which is sometimes added to make the tattoo darker. ... where it is called mehendi. Dr Bjorn Hausen, of the ...
Cached Medicine News:Health News:Cure for sleepless nights 2
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Medicine Products: